Biotechnology News

October 1, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals Announces Third Quarter 2012 Earnings Release and Conference Call

October 1, 2012

SAN FRANCISCO & SAN DIEGO--(BUSINESS WIRE)--BayBio and BIOCOM, the trade associations for the Northern and Southern California life science clusters respectively, today thanked Governor Jerry Brown and Assemblyman Jerry Hill (D-San Mateo)

October 1, 2012

LOUISVILLE, Ky.--(BUSINESS WIRE)--Pediatric Cancer Researcher Recruited to Louisville, Bringing New Treatments for Deadly Childhood Cancers.

October 1, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, presented safety and tolerance...

October 1, 2012

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA, LLC today announced the launch of Acetylcysteine Solution, USP, 20% 30 mL vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote). For inhalation, it is used as...

October 1, 2012

LAS VEGAS--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, is highlighting a wide range of innovative, recently-introduced food analysis tools at AOAC’s 2012 Annual Meeting. The company is exhibiting key...

October 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 11 abstracts from its hepatitis C research and development program will be presented at The Liver Meeting®, the 63rd Annual Meeting of the...

October 1, 2012

ATLANTA--(BUSINESS WIRE)--The 11th annual Georgia’s Life Sciences Summit, Oct. 3, 2012, will feature Johnson & Johnson CEO Alex Gorsky and Baxter Healthcare’s Brien Johnson, Vice President, Program Manager, Plasma Bioscience.

October 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--QuantiaMD and ICOS partner to engage clinicians and rapidly drive awareness, education and training around the cardiac implications of oncology treatment.

October 1, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX™ (NASDAQ: SDIX), a leading provider of biotechnology-based products and services, today announced it has entered into an agreement to sell the assets of its Food Safety and GMO businesses to Romer Labs for $13....

October 1, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--Colby receives National Cancer Institute SBIR award for Prostate Cancer Therapy

October 1, 2012

WASHINGTON--(BUSINESS WIRE)--Implementation of PDUFA V officially commences today. PhRMA and BIO stand together to usher in an exciting new era in regulatory science.

October 1, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics received a $600,000 SBIR grant from NIH to further development of a targetable bactericidal proteins to specifically kill Clostridium difficile bacteria.

October 1, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--Mass High Tech and The Boston Business Journal named Philip Lee, President & CEO of patient-driven eData systems provider PHT Corp. a “Tech Luminary” in their 2012 Innovation All Stars award program.

October 1, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for safety phlebotomy

October 1, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories, a provider of pharmaceutical and biotech drug discovery and development research services, has been named a recipient of the 2012 CRO Leadership Awards from Life Science Leader

October 1, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions announced that it has entered into a Supply Agreement with VIVUS, Inc. to supply Qsymia™ capsules, a proprietary combination phentermine and extended-release topiramate. Utilizing its...

October 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Senomyx (NASDAQ:SNMX) granted GRAS regulatory status for S9632 flavor ingredient; restores the taste profile in sucrose-reduced products; can be used in a broad range of products in the US, elsewhere

October 1, 2012

NEW YORK--(BUSINESS WIRE)--Vaccine maker KAKETSUKEN, also known as the Chemo-Sero-Therapeutic Research Institute, has become the first Japanese pharmaceutical company to use the combined capabilities of the Medidata Balance™ randomization and...

October 1, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, announced that favorable data from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate aldoxorubicin (...

October 1, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--SunTech Medical’s One-Piece Durable Cuffs™ are a new line of easily disinfected, reusable cuffs for reliable blood pressure monitoring.

October 1, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced updated survival results from the Phase III EMILIA study, which showed that people with previously treated HER2-...

October 1, 2012

MIAMI--(BUSINESS WIRE)--The Chief Technology Officer of CareCloud, a Miami-based provider of cloud-based practice management, electronic healthcare record (EHR), revenue cycle management and medical billing software and services for medical...

October 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of...

October 1, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore to provide 4 year, $500,000 grant to support promising areas of breast cancer research

October 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announces the recipients of the Genzyme Patient Advocacy Leadership Awards. The global grant program supports outreach programs by non-profit organizations that work on behalf of LSD patients.

October 1, 2012

ATLANTA--(BUSINESS WIRE)--Company speaks to their significant market expansion with Aetna to manage device and benefits coordination, billing and tracking of implantable devices nationwide.

October 1, 2012

REDMOND, Wash.--(BUSINESS WIRE)--Micronics, Inc. (www.micronics.net), a medical device development company, today announced the commercial launch of a single-use, disposable blood...

October 1, 2012

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company that discovers, develops and commercializes high value, non-invasive tests to monitor immune status in transplant recipients and autoimmune diseases, announced today...

October 1, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--New AB SCIEX Software Application Improves High-throughput Screening with QTRAP and TripleTOF Technologies

October 1, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: After the adoption of a resolution to spin off Vitrolife’s (STO:VITR) transplantation business, Vitrolife’s Board has set new financial objectives for the company. Vitrolife’s new financial...

October 1, 2012

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE employees will come together to form ‘Human Pink Ribbons’ and visually demonstrate the global fight against the disease during Breast Cancer Awareness Month

October 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO announced today that its Co-Founder, President & CEO, John Boyce, has been named a Technology Luminary as part of the 2012 Innovation All-Stars Awards selected by Mass High Tech (MHT) and the Boston...

October 1, 2012

VIENNA--(BUSINESS WIRE)--Updated Results from Phase 2b/3 GALAXY Trial Show Promising Improvement in Survival from the Addition of Ganetespib to Docetaxel in Second-Line Non-Small Cell Lung Cancer

October 1, 2012

SAN DIEGO & PLEASANTON, Calif.--(BUSINESS WIRE)--Rapid DNA analysis is a transformative technology that promises to fundamentally change the way investigations are conducted by enabling law enforcement personnel to quickly link or clear a...

October 1, 2012

CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced new data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib in 1st line advanced RCC) demonstrating the safety...

October 1, 2012

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products and its new J-Plasma™ system, today announced that the Company will present at the 2012 SeeThru...

October 1, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that it has sold to ProStrakan Group plc (ProStrakan) its rights and related assets in the metastatic breast cancer product, Fareston®, for total cash consideration of $21....

October 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that detailed results from an exploratory, randomized Phase 2 study evaluating the combination of ficlatuzumab, the company’s HGF inhibitory antibody, and gefitinib...

October 1, 2012

OKLAHOMA CITY & AUSTIN, Texas--(BUSINESS WIRE)--Pure Protein Presents Disease Discovery Research and Introduces New 120-allele HLA Class I Single Antigen Assay at American Society of Histocompatibility and Immunogenetics (ASHI) Meeting

October 1, 2012

LUND, Sweden & PARIS--(BUSINESS WIRE)--Regulatory News: Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: IPN; ADR: IPSEY) have presented a new set of data on biomarkers from the previously concluded tasquinimod Phase II study in...

October 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Collaboration between Medistem and a Chinese monoclonal antibody company based on new ways of using antibodies to activate stem cells that already exist in the body.

October 1, 2012

FREMONT, Calif.--(BUSINESS WIRE)--EXP and CACTUS have partnered to offer Smart Sink to the healthcare community providing for the disposal of raw pharmaceutical waste protecting against drug diversion and for the environment.

September 30, 2012

READING, England--(BUSINESS WIRE)--Quintiles has announced a strategic partnership with the four teaching health boards in Scotland as part of its Prime Site program to accelerate the development of new and more effective medicines

September 30, 2012

BEERSE, Belgium--(BUSINESS WIRE)--Note: Data in this release correspond to ESMO Abstracts 89501 and 89402 Additional data from pre-specified interim analyses of COU-AA-302, a Phase III, randomised, placebo-controlled study, suggested ZYTIGA® (...

September 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced interim data from 51 patients with metastatic castration-resistant prostate cancer (CRPC) and bone metastases receiving a 40 mg daily dose of cabozantinib...

September 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported preliminary data from an ongoing phase 1 dose escalation study of cabozantinib in Japan. Hiroshi Nokihara, M.D., Ph.D., a physician at the National Cancer...

September 29, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced four- and five-year survival rates based on long-term follow up from Phase 3 and Phase 2 YERVOY® (ipilimumab) clinical trials in patients with treatment-...

September 29, 2012

VIENNA & CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the initial clinical results on its investigational, tyrosine-kinase inhibitor, AP26113, in patients with advanced non-small cell lung...